UiPath (PATH) began its journey with a focus on robotic process automation (RPA) and has since evolved into a comprehensive automation powerhouse. The company, traded on the NYSE under the ticker PATH, offers an AI-driven business automation platform designed to help organizations create software robots. These bots are capable of mimicking human actions, enabling businesses to streamline repetitive tasks and optimize routine processes with greater efficiency.
Why Does PATH Give Us Pause?
Despite its strong market position and technological evolution, several factors raise concerns for investors:
Over the past two years, UiPath has delivered annual revenue growth of 11.2% , which is notably slower than the growth rates achieved by many of its software industry peers during the same period.
Customer hesitation has become more apparent over the last year, as reflected in the company’s average billings growth of just 9.3% —an underwhelming figure that suggests clients are thinking twice before committing to its platform.
Looking ahead, estimated sales growth of 8.4% over the next 12 months points to a potential deceleration in demand, implying that future growth could fall short of the company’s two-year historical trend.
Currently, UiPath is trading at $11.06 per share, which represents a 3.2x forward price-to-sales multiple. This valuation, combined with the slowing growth metrics, underscores why some investors are approaching PATH with increased caution.